Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 654

1.

Transplantation of Human Amniotic Membrane over the Liver Surface Reduces Hepatic Fibrosis in a Cholestatic Model in Young Rats.

Garrido M, Escobar C, Zamora C, Rejas C, Varas J, Córdova C, Papuzinski C, Párraga M, San Martín S, Montedonico S.

Stem Cells Int. 2018 Feb 25;2018:6169546. doi: 10.1155/2018/6169546. eCollection 2018.

2.

Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease.

Tedesco D, Thapa M, Chin CY, Ge Y, Gong M, Li J, Gumber S, Speck P, Elrod EJ, Burd EM, Kitchens WH, Magliocca JF, Adams AB, Weiss DS, Mohamadzadeh M, Grakoui A.

Gastroenterology. 2018 Jun;154(8):2178-2193. doi: 10.1053/j.gastro.2018.02.019. Epub 2018 Feb 15.

PMID:
29454797
3.

Environmental basis of primary biliary cholangitis.

Tanaka A, Leung PS, Gershwin ME.

Exp Biol Med (Maywood). 2018 Jan;243(2):184-189. doi: 10.1177/1535370217748893. Epub 2018 Jan 7.

PMID:
29307284
4.

Establishment of a surgical bile duct injection technique giving direct access to the bile ducts for studies of the murine biliary tree.

Berntsen NL, Fosby B, Valestrand L, Tan C, Reims HM, Schrumpf E, Karlsen TH, Line PD, Melum E.

Am J Physiol Gastrointest Liver Physiol. 2018 Mar 1;314(3):G349-G359. doi: 10.1152/ajpgi.00124.2017. Epub 2017 Dec 6.

PMID:
29212771
5.

A Novel Pkhd1 Mutation Interacts with the Nonobese Diabetic Genetic Background To Cause Autoimmune Cholangitis.

Huang W, Rainbow DB, Wu Y, Adams D, Shivakumar P, Kottyan L, Karns R, Aronow B, Bezerra J, Gershwin ME, Peterson LB, Wicker LS, Ridgway WM.

J Immunol. 2018 Jan 1;200(1):147-162. doi: 10.4049/jimmunol.1701087. Epub 2017 Nov 20.

6.

Effect of Huagantongluofang, a Chinese Traditional Medicine, in Hepatic Fibrogenesis in a Mouse Model of Biliary Cirrhosis.

Xuan J, Wen W, Wang Y, Wang F, Xu HB, Shao M, Yang Y, Tian YZ.

Cell Physiol Biochem. 2017;44(1):368-376. doi: 10.1159/000484908. Epub 2017 Nov 13.

7.

SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis.

Athwal VS, Pritchett J, Llewellyn J, Martin K, Camacho E, Raza SM, Phythian-Adams A, Birchall LJ, Mullan AF, Su K, Pearmain L, Dolman G, Zaitoun AM, Friedman SL, MacDonald A, Irving WL, Guha IN, Hanley NA, Piper Hanley K.

EMBO Mol Med. 2017 Dec;9(12):1696-1710. doi: 10.15252/emmm.201707860.

8.

Bile duct ligature in young rats: A revisited animal model for biliary atresia.

Garrido M, Escobar C, Zamora C, Rejas C, Varas J, Párraga M, San Martin S, Montedónico S.

Eur J Histochem. 2017 Sep 13;61(3):2803. doi: 10.4081/ejh.2017.2803.

9.

Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis.

Dufton NP, Peghaire CR, Osuna-Almagro L, Raimondi C, Kalna V, Chuahan A, Webb G, Yang Y, Birdsey GM, Lalor P, Mason JC, Adams DH, Randi AM.

Nat Commun. 2017 Oct 12;8(1):895. doi: 10.1038/s41467-017-01169-0.

10.

Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: Potential role for silent information regulator 1 (SIRT1).

Abd El Motteleb DM, Ibrahim IAAE, Elshazly SM.

Toxicol Appl Pharmacol. 2017 Nov 15;335:64-71. doi: 10.1016/j.taap.2017.09.021. Epub 2017 Sep 30.

PMID:
28974454
11.

Investigational drugs in phase II clinical trials for primary biliary cholangitis.

Silveira MG, Lindor KD.

Expert Opin Investig Drugs. 2017 Oct;26(10):1115-1121. doi: 10.1080/13543784.2017.1371135. Epub 2017 Aug 31. Review.

PMID:
28836457
12.

Melatonin inhibits hypothalamic gonadotropin-releasing hormone release and reduces biliary hyperplasia and fibrosis in cholestatic rats.

McMillin M, DeMorrow S, Glaser S, Venter J, Kyritsi K, Zhou T, Grant S, Giang T, Greene JF Jr, Wu N, Jefferson B, Meng F, Alpini G.

Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1;313(5):G410-G418. doi: 10.1152/ajpgi.00421.2016. Epub 2017 Jul 27.

PMID:
28751425
13.

Induction of chronic cholestasis without liver cirrhosis - Creation of an animal model.

Dondorf F, Fahrner R, Ardelt M, Patsenker E, Stickel F, Dahmen U, Settmacher U, Rauchfuß F.

World J Gastroenterol. 2017 Jun 21;23(23):4191-4199. doi: 10.3748/wjg.v23.i23.4191.

14.

Bone marrow endothelial progenitor cells activate hepatic stellate cells and aggravate carbon tetrachloride induced liver fibrosis in mice via paracrine factors.

Garg M, Kaur S, Banik A, Kumar V, Rastogi A, Sarin SK, Mukhopadhyay A, Trehanpati N.

Cell Prolif. 2017 Aug;50(4). doi: 10.1111/cpr.12355. Epub 2017 Jul 6.

PMID:
28682508
15.

Long-term effects of human amniotic membrane in a rat model of biliary fibrosis.

Sant'Anna LB, Brito FS, Barja PR, Nicodemo MC.

Braz J Med Biol Res. 2017 Jul 3;50(7):e5692. doi: 10.1590/1414-431X20175692.

16.

Increased hepatic ABCA1 transporter is associated with hypercholesterolemia in a cholestatic rat model and primary biliary cholangitis patients.

Takeyama Y, Uehara Y, Anan A, Morihara D, Yokoyama K, Takata K, Tanaka T, Irie M, Iwata K, Shakado S, Sohda T, Sakisaka S.

Med Mol Morphol. 2017 Dec;50(4):227-237. doi: 10.1007/s00795-017-0166-7. Epub 2017 Jun 28.

PMID:
28660384
17.

Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.

Wu N, Meng F, Zhou T, Han Y, Kennedy L, Venter J, Francis H, DeMorrow S, Onori P, Invernizzi P, Bernuzzi F, Mancinelli R, Gaudio E, Franchitto A, Glaser S, Alpini G.

FASEB J. 2017 Oct;31(10):4305-4324. doi: 10.1096/fj.201700097R. Epub 2017 Jun 20.

PMID:
28634212
18.

Knockdown of Hepatic Gonadotropin-Releasing Hormone by Vivo-Morpholino Decreases Liver Fibrosis in Multidrug Resistance Gene 2 Knockout Mice by Down-Regulation of miR-200b.

Kyritsi K, Meng F, Zhou T, Wu N, Venter J, Francis H, Kennedy L, Onori P, Franchitto A, Bernuzzi F, Invernizzi P, McDaniel K, Mancinelli R, Alvaro D, Gaudio E, Alpini G, Glaser S.

Am J Pathol. 2017 Jul;187(7):1551-1565. doi: 10.1016/j.ajpath.2017.03.013. Epub 2017 May 12.

19.

Adipose-derived mesenchymal stem cells slow disease progression of acute-on-chronic liver failure.

Gilsanz C, Aller MA, Fuentes-Julian S, Prieto I, Blázquez-Martinez A, Argudo S, Fernández-Delgado J, Beleña J, Arias J, De Miguel MP.

Biomed Pharmacother. 2017 Jul;91:776-787. doi: 10.1016/j.biopha.2017.04.117. Epub 2017 May 10.

PMID:
28501004
20.

Catheter-directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis.

Lee KS, Santagostino SF, Li D, Ramjit A, Serrano K, Ginsberg MD, Ding BS, Rafii S, Madoff DC.

Radiology. 2017 Oct;285(1):114-123. doi: 10.1148/radiol.2017162617. Epub 2017 May 11.

PMID:
28498793

Supplemental Content

Loading ...
Support Center